A new study published in JAMA Pediatrics reveals that fewer than 1 in 1,000 adolescents with commercial insurance received gender-affirming medications (puberty blockers or hormones) between 2018 and 2022.
As U.S. lawmakers debate issues around health care for transgender youth , it’s been difficult to determine the number of young people receiving gender-affirming medications . Now, a medical journal has published the most reliable estimate yet and the numbers are low, reflecting more clearly on medical practices. Fewer than 1 in 1,000 U.S.
adolescents with commercial insurance received gender-affirming medications — puberty blockers or hormones — during a recent five-year period, according to the study released Monday. At least 26 states have adopted laws restricting or banning gender-affirming medical care for transgender minors, and most of those states face lawsuits. A decision by the Supreme Court in a Tennessee case is expected later this year. President-elect Donald Trump has promised to roll back protections for transgender people. “We are not seeing inappropriate use of this sort of care,' said lead author Landon Hughes, a Harvard University public health researcher. “And it’s certainly not happening at the rate at which people often think it is.” The researchers analyzed a large insurance claims database covering more than 5 million patients ages 8 to 17. Only 926 adolescents with a gender-related diagnosis received puberty blockers from 2018 through 2022. During that time, 1,927 received hormones. The findings, published in JAMA Pediatrics, suggest that fewer than 0.2% of adolescents with commercial insurance received gender-affirming medications during the study period
Healthcare Transgender Youth Gender-Affirming Medications Study JAMA Pediatrics
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drinking Beer or Wine May Prevent Arthritis, New Study FindsAbby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she worked in medical writing, covering neurological news for healthcare professionals. In 2020, she published her nonfiction history book, The Marine Society of the City of New York 1770-2020, with Fort Schuyler Press.
Read more »
Zebrafish, lizards use sleeping genes to restore hearing power, finds new studyThe discovery provides insight into the mechanisms that could one day help humans recover from hearing loss and balance disorders.
Read more »
U.S. 'fondness for tall SUVs and pickups' compounding risks for pedestrians in crashes, IIHS study findsThe IIHS says a 'small increase in crash speed can really ramp up the danger to a pedestrian,' and our penchant for big vehicles 'has intensified that effect.'
Read more »
Ultra-processed foods may drive colorectal cancer risk, study findsA new study suggests that ultra-processed foods and inflammatory seed oils used in packaged food products may contribute to chronic inflammation, fueling colorectal cancer.
Read more »
US Study Finds Low Rate of Gender-Affirming Care for Transgender YouthA new study published in JAMA Pediatrics reveals that the rate of gender-affirming medical care for transgender youth is significantly lower than previously thought.
Read more »
Study Finds Fewer Than 1 in 1,000 Transgender Youth Receive Hormone TherapyA new study published in JAMA Pediatrics reveals that fewer than 1 in 1,000 U.S. transgender youth are receiving hormone therapy, providing the most reliable estimate yet.
Read more »